tiprankstipranks
Trending News
More News >
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Stock Investors

Compare
59 Followers
Based on 795,221 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLYM
On average, investors allocate 0.00% of their portfolios to CLYM
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 795,221 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLYM

4.2%
Last 7
Days
7.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLYM, out of 795,221 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLYM Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in CLYM in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLYM Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Lucid Group
5.45%
-0.17%
+1.97%
7.73B
Consumer Cyclical
Riot Platforms
4.59%
-1.45%
-2.40%
2.58B
Financial
Nio
8.77%
-0.92%
-1.26%
6.81B
Consumer Cyclical
Star Bulk Carriers
4.40%
-1.54%
-4.14%
1.58B
Industrials
Sirius XM Holdings
3.27%
-1.12%
-4.77%
7.08B
Communication Services
Recursion Pharmaceuticals
3.17%
-1.29%
-2.71%
1.87B
Healthcare
Enterprise Products Partners
5.45%
-0.88%
-0.90%
64.30B
Energy
Block
3.65%
+0.78%
+3.60%
34.68B
Technology
Intuitive Surgical
3.61%
-0.76%
+3.26%
187.36B
Healthcare
CVS Health
4.47%
+0.98%
+0.24%
88.59B
Healthcare
Based on the activity of 795,221 active portfolios
Open your Smart Portfolio

CLYM Investor Analysis

CLYM investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of CLYM holders
are under 35
Average Segment Performance
Average P/E Ratio16.83
Beta5.56
Dividend Yield4.09%
CLYM investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
100.0%
of CLYM holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.92
Beta13.64
Dividend Yield3.58%
CLYM investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
0.0%
of CLYM holders
are over 55
Average Segment Performance
Average P/E Ratio13.94
Beta8.07
Dividend Yield3.86%
Overview of age group and performance of CLYM stock investors
See who invests in CLYM according to age group and performance.

FAQ

How many retail Investors hold CLYM?
<0.1% of TipRanks' retail investors hold CLYM in their portfolios.
    What is CLYM Investor Sentiment?
    CLYM’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CLYM in the last 7 days?
      ▲ 4.2% of TipRanks' retail investors changed their holding of CLYM in the last 7 days.
        What percentage of retail investors changed their holding of CLYM in the last 30 days?
        ▲ 7.1% of TipRanks' retail investors changed their holding of CLYM in the last 30 days.
          What is the average age of retail investors who hold CLYM?
          The average age of CLYM Holders is between 35–55.
            What other stocks have CLYM investors also bought?
            CLYM Investors also bought LCID, RIOT, NIO, SBLK, SIRI, RXRX, EPD, XYZ, ISRG, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              CORCencora
              ANGOAngioDynamics
              CNCCentene
              DHRDanaher
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis